GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (FRA:DTC) » Definitions » Pre-Tax Income

Defence Therapeutics (FRA:DTC) Pre-Tax Income : €-8.11 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Defence Therapeutics's pretax income for the three months ended in Mar. 2024 was €-0.90 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €-8.11 Mil. Defence Therapeutics's pretax margin was %.


Defence Therapeutics Pre-Tax Income Historical Data

The historical data trend for Defence Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Pre-Tax Income Chart

Defence Therapeutics Annual Data
Trend Jun20 Jun21 Jun22
Pre-Tax Income
-0.44 -1.94 -5.43

Defence Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.38 -0.92 -1.52 -5.69 -0.90

Competitive Comparison of Defence Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Defence Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Defence Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Defence Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Defence Therapeutics's Pre-Tax Income falls into.



Defence Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Defence Therapeutics's Pretax Income for the fiscal year that ended in Jun. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-5.408+-0.018+0+0+0
=-5.43

Defence Therapeutics's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.822+-0.016+-0.065+0.001+-0.001
=-0.90

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-8.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Defence Therapeutics  (FRA:DTC) Pre-Tax Income Explanation

Defence Therapeutics's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.903/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Defence Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Defence Therapeutics (FRA:DTC) Business Description

Traded in Other Exchanges
Address
200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.